Safety of ipilimumab in patients (pts) with untreated, advanced melanoma alive beyond 2 years: Results from a phase III study Meeting Abstract


Authors: Thomas, L.; Wolchok, J. D.; Garbe, C.; Lebbe, C.; Bondarenko, I.; Rodrigues, K.; Konto, C.; Chin, K. M.; Francis, S.; Robert, C.
Abstract Title: Safety of ipilimumab in patients (pts) with untreated, advanced melanoma alive beyond 2 years: Results from a phase III study
Meeting Title: 48th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 30
Issue: 15 Suppl.
Meeting Dates: 2012 Jun 1-5
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2012-05-20
Language: English
ACCESSION: WOS:000318009802113
PROVIDER: wos
DOI: 10.1200/jco.2012.30.15_suppl.8512
Notes: Meeting Abstract: 8512 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Jedd D Wolchok
    905 Wolchok